| Autor: |
Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Department of Biomedicine and Prevention, Phd in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy., Durrani J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Pagliuca S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kishtagari A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kerr CM; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Adema V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kongkiatkamon S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Lichtin AE; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Patel BJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Sekeres MA; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Cook JR; Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA. maciejj@ccf.org.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA. maciejj@ccf.org. |
Full text from SpringerLink